皮质类固醇注射和骨折风险
Terin T Sytsma1, Shannon Thomas2, Karen M Fischer3
1Division of Community Internal Medicine, Geriatrics, and Palliative Care, Mayo Clinic, Rochester, Minnesota.
JAMA network open
|May 31, 2024
概括
皮质类固醇注射 (CSI) 不会增加骨折风险,即使在患有骨质疏松症的患者中也是如此. 临床医生可以自信地使用CSI来缓解疼痛,而不必担心骨健康并发症.
科学领域:
- 肌肉骨健康 肌肉骨健康
- 骨的新陈代谢 骨的新陈代谢
- 药理学 药理学是指药理学的学科.
背景情况:
- 皮质类固醇注射 (CSI) 广泛用于肌肉骨疼痛缓解.
- 骨损伤对骨健康和骨折风险的长度影响仍然不清楚.
研究的目的:
- 为了研究累积的皮质类固醇注射剂量与随后的骨折风险之间的关联.
- 评估接受CSI的骨质疏松症和没有骨质疏松症患者的骨折风险.
主要方法:
- 在2018年5月至2022年7月期间接受CSI的7197名成年患者的队列研究.
- 考克斯的比例危险回归模型分析骨折风险基于累计的CSI剂量 (triamcinolone等价物).
- 小组分析包括没有高骨折风险的患者和患有骨质疏松症的患者.
主要成果:
- 较高的累积CSI剂量和骨折风险增加之间没有发现任何关联 (调整HR,1.04).
- 这种缺乏关联对于不处于高风险的患者 (调整HR,1.11) 和患有骨质疏松症的患者 (调整HR,1.01) 的子组是正确的.
- 年龄,查尔森并发症指数和先前的骨折是骨折的重要危险因素.
结论:
- 累积的皮质类固醇注射剂量与随后骨折的风险增加无关.
- 对疼痛疾病的CSI治疗可以在不必担心骨折风险的情况下进行,即使在患有骨质疏松症的患者中也是如此.
- 关于CSI的临床决定不应该被潜在的骨折风险所阻止.
相关概念视频
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
115
Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2...
115
Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids
236
Inhaled corticosteroids (ICS) are anti-inflammatory drugs used primarily in treating persistent asthma and providing long-term maintenance. They target the bronchial mucosa, the lining of the airways, to control inflammation, a critical factor in asthma progression and exacerbation.
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
236
Fractures: Bone Repair
3.2K
Treatment for a fracture is based on the type of break, the bone affected, and the patient's age.
Minor fractures with no bone displacement are treated by immobilizing the fractured bone using a cast or splint. However, in the case of fractures with displaced bones, the broken bones are repositioned before immobilization to ensure successful healing without deformation and loss of function. The realignment of fractured bone ends is performed through a process called reduction. If the...
Minor fractures with no bone displacement are treated by immobilizing the fractured bone using a cast or splint. However, in the case of fractures with displaced bones, the broken bones are repositioned before immobilization to ensure successful healing without deformation and loss of function. The realignment of fractured bone ends is performed through a process called reduction. If the...
3.2K
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
157
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
157
COPD: Management Using Bronchodilators and Corticosteroids
195
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
195
Bone Disorders
3.5K
Aging and its effect on bone remodeling is the most common cause of bone disorders. In young and healthy people, bone deposition and resorption happen at an equal rate to maintain optimal bone health.
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
3.5K


